Download Files:
Products Details
Product Description
– Tomopenem (CS-023; RO4908463; R-115685) is a longer-half-life parenteral carbapenem. Tomopenem shows broad activity against 63 reference species. The activity of tomopenem against 293 clinical isolates is potent (MIC90, 0.06 to 4 μg/mL). Antianaerobic activity[1].
Web ID
– HY-123022
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C23H35N7O6S
References
– [1]Kaori Tanaka, et al. In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria. Antimicrob Agents Chemother. 2009 Jan;53(1):319-22.
CAS Number
– 222400-20-6
Molecular Weight
– 537.63
SMILES
– OC(C1=C(S[C@H]2C[C@H](N(C2)C)C(N3C[C@H](CC3)NC(CNC(N)=N)=O)=O)[C@H](C)[C@@]([C@@]4([H])[C@H](O)C)([H])N1C4=O)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Bacterial
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
